[Cancer of the maxillary sinus. A retrospective study of 29 cases].
Representing 2% of malignant tumors and 6% of head and neck cancer, almost always diagnosed at a late stage, maxillary sinus cancer still remains a rather rare pathology but fearsome prognosis. From the 29 cases, over 10 years of follow up at the clinic and Paul Strauss cancer treatment center, this study focuses mainly on two criteria: diagnosis, in the study of the presenting symptoms in order to treat this pathology as soon as possible; therapeutic, by analysing our results, and by focusing on the current treatment.
Debry
C
C
Service ORL, Hospices Civils, Strasbourg.
Bouillon
F
F
Methlin
A
A
Jung
C
C
Conraux
C
C
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003528:Carcinoma, Adenoid Cystic / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D008444:Maxillary Sinus Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D008875:Middle Aged; D010255:Paranasal Sinus Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D011379:Prognosis; D012189:Retrospective Studies
Cancers du maxillaire supérieur. Etude rétrospective à partir de 29 cas.